Close Menu

NEW YORK (GenomeWeb) – Roche said today that it has received the CE IVD mark for its Cobas HPV assay on the Cobas 6800/8800 systems for cervical cancer screening.

Cobas HPV is a real-time PCR test that provides specific genotyping information for human papillomavirus 16 and 18, the highest-risk types, while simultaneously reporting the 12 other high-risk HPV types as a pooled result.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Feb
23
Sponsored by
Thermo Fisher Scientific

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before. 

Feb
24
Sponsored by
SCHOTT MINIFAB

Developing a fully integrated consumable cartridge for an automated diagnostic platform is a significant challenge. More challenging still is developing such a cartridge in response to a deadly global virus pandemic amid market uncertainty and extraordinary time constraints.